Commure Acquires Augmedix for $139M
July 25, 2024
Commure, a Mountain View-based healthcare software company, will acquire Augmedix, an AI-enabled clinical documentation and ambient scribing provider, in a transaction valued at $139 million that will take Augmedix private. The combined company aims to integrate ambient AI scribing, revenue-cycle automation, and large-language-model capabilities to reduce clinician documentation burden and accelerate product innovation.
- Buyers
- Commure
- Targets
- Augmedix
- Sellers
- Augmedix stockholders
- Industry
- Healthcare Services
- Location
- California, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Commure Acquires Memora Health
December 27, 2024
Healthcare Services
Commure, a Mountain View–based healthcare technology company, has acquired Memora Health, a San Francisco–based digital care navigation platform. The deal brings Memora's AI-enabled patient navigation and care automation capabilities into CommureOS to strengthen patient engagement, care pathway personalization, and Commure's broader AI-powered clinical and operational offerings.
-
Sutherland Acquires Augment CXM
September 22, 2022
AI & Machine Learning
Sutherland, an experience-led digital transformation company, has acquired AI-based customer experience platform Augment CXM to expand its AI solutions portfolio and enhance customer journey capabilities. The acquisition integrates Augment CXM's conversational AI technology with Sutherland's human-in-the-loop AI and automation to improve agent efficiency, conversion rates and overall customer satisfaction for global brands.
-
R1 RCM Completes Acquisition of Cloudmed
June 21, 2022
Healthcare Services
R1 RCM Inc. completed its previously announced acquisition of Cloudmed in an all-stock transaction valuing Cloudmed at approximately $4.1 billion, including $857 million of net debt. The combined company is positioned to deliver an integrated healthcare revenue cycle management platform with enhanced automation and AI capabilities to improve provider revenue and financial performance.
-
Sanofi Acquires Amunix Pharmaceuticals
December 21, 2021
Biotechnology
Sanofi has entered into an agreement to acquire Amunix Pharmaceuticals for an upfront payment of approximately $1.0 billion plus up to $225 million in potential development milestones. The acquisition gives Sanofi Amunix’s Pro‑XTEN/XPAT/XPAC masking technology and a pipeline of conditionally activated T‑cell engagers and cytokine therapies (including lead candidate AMX‑818), expanding Sanofi’s immuno‑oncology capabilities.
-
MediSpend Acquires MedCompli
May 22, 2024
Software
MediSpend, a Portsmouth, New Hampshire–based commercial compliance technology company, has acquired MedCompli, a life-sciences compliance software and services provider, effective May 17, 2024. The acquisition expands MediSpend’s product portfolio and subject-matter expertise—bringing complementary SaaS and advisory capabilities into its PE-backed platform to better serve life sciences customers globally.
-
HealthMark Group Acquires Purview
February 12, 2026
Healthcare Services
HealthMark Group acquired Purview, a cloud-based medical imaging company based in Annapolis, Maryland. The acquisition is intended to modernize how medical imaging is ingested, analyzed, and shared—moving away from widespread reliance on physical discs—by integrating Purview into HealthMark’s clinical data exchange solution.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.